Enanta Pharmaceuticals Announces Update to its Hepatitis B Virus (HBV) Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. META
9. AMC
10. ACN

Go back to Enanta Pharmaceuticals Announces Update to its Hepatitis B Virus (HBV) Program
ENANTA PHARM (NASDAQ: ENTA) Delayed: 12.11 -0.09 (0.74%)
Previous Close $12.20    52 Week High $34.49 
Open $12.28    52 Week Low $20.39 
Day High $12.28    P/E N/A 
Day Low $11.94    EPS $-3.18 
Volume 217,216